Ellen C Zwarthoff Selected Research

Ellen C Zwarthoff Research Topics

Disease

37	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2002
33	Neoplasms (Cancer) 01/2022 - 01/2006
12	Carcinoma (Carcinomatosis) 01/2021 - 01/2003
7	Non-Muscle Invasive Bladder Neoplasms 01/2021 - 06/2010
3	Hematuria 01/2017 - 11/2010
3	Meningioma (Meningiomas) 07/2009 - 02/2007
2	Carcinogenesis 05/2015 - 09/2005
2	Melanoma (Melanoma, Malignant) 11/2014 - 08/2014
2	Uveal melanoma 08/2014 - 06/2004
2	Nevus (Nevi) 08/2014 - 08/2006
2	Leukemia 01/2012 - 02/2007
2	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 08/2006 - 12/2002
2	Achondroplasia 08/2006 - 12/2002
1	Disease Progression 05/2015
1	Glioma (Gliomas) 11/2014
1	Residual Neoplasm 08/2012
1	Necrosis 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 05/2011
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2008
1	Pain (Aches) 05/2008
1	Seborrheic Keratosis 08/2007
1	Acanthosis Nigricans 08/2006
1	Microsatellite Instability 01/2006
1	Craniosynostoses (Craniosynostosis) 12/2002

Drug/Important Bio-Agent (IBA)

15	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 12/2002
14	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2008
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2006
4	Biological ProductsIBA 01/2021 - 05/2015
4	Phenobarbital (Luminal)FDA Link 10/2019 - 05/2010
4	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2014 - 02/2014
4	Codon (Codons)IBA 01/2010 - 12/2002
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
2	Peptides (Polypeptides)IBA 01/2019 - 08/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 10/2017
2	Indicators and Reagents (Reagents)IBA 10/2016 - 11/2015
2	ParaffinIBA 08/2014 - 05/2012
2	Formaldehyde (Formol)FDA Link 08/2014 - 05/2012
2	nuclear matrix protein 22IBA 07/2013 - 11/2010
2	Phosphotransferases (Kinase)IBA 11/2009 - 04/2009
1	Penfluridol (Semap)IBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	Chemokine ReceptorsIBA 12/2020
1	ChemokinesIBA 12/2020
1	PPAR gammaIBA 12/2020
1	SolutionsIBA 10/2019
1	Long Noncoding RNAIBA 10/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	ClaudinsIBA 10/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	PlatinumIBA 07/2016
1	CateninsIBA 05/2015
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 05/2015
1	Cadherins (E-Cadherin)IBA 05/2015
1	Interleukin-18 (Interleukin 18)IBA 01/2012
1	InterleukinsIBA 01/2012
1	LigandsIBA 01/2012
1	Genetic Markers (Genetic Marker)IBA 01/2012
1	CytokinesIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Endothelins (Endothelin)IBA 11/2009
1	Endothelin-1 (Endothelin 1)IBA 11/2009
1	1,25-dihydroxyvitamin DIBA 07/2009
1	Oncogene Proteins (Oncogene Protein)IBA 10/2008
1	cupric sulfide (CuS)IBA 05/2008
1	Fibroblast Growth Factor 3IBA 08/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2007
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2007
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2006
1	Proto-Oncogene Proteins B-rafIBA 06/2004

Therapy/Procedure

9	Therapeutics 12/2020 - 11/2009
6	Cystectomy 01/2022 - 08/2012
3	Neoadjuvant Therapy 01/2019 - 01/2017
3	Drug Therapy (Chemotherapy) 07/2016 - 10/2008
2	Nephroureterectomy 01/2021 - 01/2020
2	Intravesical Administration 12/2020 - 01/2012
1	Aftercare (After-Treatment) 09/2017
1	Transurethral Resection of Bladder 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Precision Medicine 04/2015
1	Ligation 03/2012
1	Immunotherapy 01/2012
1	Conservative Treatment 05/2011
1	Cystoscopes 05/2008
1	Radiotherapy 04/2003